Share Talk Ltd

ImmuPharma PLC (AIM: IMM) CEO Tim McCarthy spoke with Zak Mir. In the world of biotechnology, companies often face unique challenges, particularly when it comes to navigating public markets and securing investment. Tim McCarthy, CEO of ImmuPharma, shares his insights on the current state of the biotech industry, the innovations at ImmuPharma, and the importance of effective communication with investors. Join us as we delve into ImmuPharma's transformative journey, the significance of its groundbreaking research, and what the future holds for the company. The Landscape of Biotech Investment Tim opens the discussion by acknowledging the struggles that biotech firms, especially those listed on the London market, often encounter. The UK and Europe lack the depth of capital markets that are available in the US, making it more challenging for biotech companies to thrive. Tim reflects on his extensive experience in the sector. He highlights that the primary issue is not just access to capital but also the underst